Sponsor pipeline

Cartesian Therapeutics clinical trial pipeline

Get alerts when Cartesian Therapeutics's trials change

5 active trials 2 recruiting 1 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1/2
1
Phase 2
3
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06799247 Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach… Myasthaenia Gravis Active, Not Recruiting 2026-09-01
Phase 2
NCT07391605 Descartes-08 in Autoantibody Myositis Antisynthetase Syndrome Recruiting 2026-08-17
NCT04146051 Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) Myasthenia Gravis, Generalized Active, Not Recruiting 2026-08-14
NCT06038474 Descartes-08 for Patients With Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE) Active, Not Recruiting 2026-03-27
Phase 1/2
NCT07089121 Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders Childhood-onset Systemic Lupus Erythematous Recruiting 2026-07-27

Disease areas by active trials

Get alerts when Cartesian Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free